Article
Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. Swiss HIV Cohort Study.
AIDS (London, England) - 5 May 2000
Khanna N, Klimkait T, Schiffer V, Irigoyen J, Telenti A, Hirschel B, Battegay M
Abstract excerpt
BACKGROUND: Highly active antiretroviral therapy (HAART) may fail, especially in pre-treated patients. OBJECTIVE: To examine retrospectively whether heavily pre-treated patients not responding to HAART at least once respond to a salvage therapy with abacavir, a nucleoside reverse transcriptase inhibitor (NRTI) plus a non-nucleoside analogue reverse transcriptase inhibitor (NNRTI) and one or two protease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.